Maravai LifeSciences Holdings, Inc. MRVI Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s other commercial liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported other commercial liabilities of $28.65M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s other commercial liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s other commercial liabilities decreased by 35.8% year-over-year, from $44.6M to $28.65M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s other commercial liabilities has grown at a -1.0% compound annual growth rate (CAGR), from $38.55M to $36.57M.